SCCM Resource Library-Managing Anticoagulants and Antiplatelet Agents in the ICU

Video Transcription

Video Summary

The video discusses updates in antiplatelet and anticoagulant medications, specifically in critical care patients. It covers studies on managing patients with concomitant atrial fibrillation and percutaneous coronary intervention, as well as the duration of dual antiplatelet therapy. The video also explores the use of periprocedural bridging with anticoagulants during surgical interventions and the choice of P2Y12 receptor antagonists in acute coronary syndromes. It highlights recent advances in anticoagulant therapy, including the use of direct oral anticoagulants in preventing and treating venous thromboembolism in cancer patients, and their potential use in heparin-induced thrombocytopenia. The video also discusses the need for more research in anticoagulation and the potential of precision medicine in trauma-induced coagulopathy. <br /><br />Additionally, the video transcript focuses on the use of thromboelastometry (TEG) and rotational thromboelastometry (ROTEM) tests in measuring coagulation. It explains that these tests provide a more comprehensive view of coagulation compared to standard tests and can guide personalized transfusion therapy, leading to reduced blood product usage and improved outcomes. However, the challenges of using TEG and ROTEM in patients on anticoagulation therapy are also mentioned. The video emphasizes the importance of considering factors such as metabolism and patient history when choosing anticoagulants for specific indications. It also addresses the challenges in managing prolonged thrombocytopenia in patients, particularly after trauma, due to platelet dysfunction and reduced platelet production. The speakers stress the value of TEG and ROTEM in assessing coagulation and guiding transfusion therapy, while acknowledging the need for further research and clinical judgment in individual patient management.

Asset Subtitle

Pharmacology, Hematology, 2020

Asset Caption

The Society of Critical Care Medicine's Critical Care Congress features internationally renowned faculty and content sessions highlighting the most up-to-date, evidence-based developments in critical care medicine. This is a presentation from the 2020 Critical Care Congress held February 16-19, 2020, in Orlando, Florida, USA.

Learning Objectives

Differentiate between the latest anticoagulant and antiplatelet agents our patients may be taking and these agents' varied effects on outcome
Adopt the latest practice management guidelines on the balanced resuscitation of trauma-induced coagulopathy
Compare and contrast the advantages and disadvantages of viscoelastic tests (eg, thromboelastography) in the assessment and treatment of coagulopathy and platelet dysfunction

Update in Antiplatelet and Anticoagulant Medications

Toby C. Trujillo

What's New on the Horizon: Precision Medicine, Acute Traumatic Coagulopathy and Endotheliopathy

Mitchell Jay Cohen

Thrombelastometry: An Essential Tool to Assess Coagulopathy

Martin A. Schreiber

Meta Tag

Content Type Presentation

Knowledge Area Pharmacology

Knowledge Area Hematology

Knowledge Level Intermediate

Membership Level Select

Membership Level Professional

Membership Level Associate

Tag Anticoagulation

Tag Transfusion

Tag Coagulation

Year 2020

Keywords

antiplatelet medications

anticoagulant medications

critical care patients

atrial fibrillation

percutaneous coronary intervention

dual antiplatelet therapy

thromboelastometry

rotational thromboelastometry

coagulation tests

personalized transfusion therapy

clinical judgment

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.